Allurion’s intragastric balloon has demonstrated yet more positive efficacy and safety results in a study on patients living obesity, though the company continues to struggle with weakening ...

Allurion intragastric ballon demonstrated a good safety profile, with no reported serious adverse events or premature device removals. Allurion’s gastric balloon has been available in Europe ...

The open-label, multicenter, randomized AUDACITY trial (ClinicalTrials.gov Identifier: NCT05368259) evaluated the safety and efficacy of the Allurion Gastric Balloon in adults aged 22 to 65 years ...

The rate of serious adverse events in Allurion Balloon subjects in the AUDACITY trial was 3.1%, the lowest reported in a pivotal FDA trial for a liquid-filled intragastric balloon indicated for ...

The Allurion intragastric balloon (IGB) is inserted through the mouth into the patient's stomach endoscopically before being expanded with 550 milliliters of water. Aqilah Yunus 30 (left-black shirt), ...

The Allurion swallowable intragastric balloon is a safe and effective method of losing weight without surgery. (Allurion pic) The rising prevalence of overweight and obesity among adults in ...

Shares of Allurion Technologies rallied after the company said patients lost weight and maintained muscle mass while using its Allurion Balloon and AI-Powered Virtual Care Suite. The stock rose 42 ...

2 The Allurion Balloon has not been compared to other liquid-filled intragastric balloons in a head-to-head study for weight loss or for frequency or type of adverse events. 3 Ienca et al. Obesity ...

Allurion has added more efficacy and safety data to support its intragastric balloon, but popularity of GLP-1 drugs shows no signs of slowing.

The Allurion intragastric balloon (IGB) is inserted through the mouth into the patient's stomach endoscopically before being expanded with 550 milliliters of water. “Over the past decade, demand for ...